InvestSMART

Bod Australia Limited (ASX: BDA) - Announcements

Current share price for BDA : $0.270 0.005 (1.82%)+

ASX company news and announcements for Bod Australia Limited (BDA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bod Australia Limited (BDA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bod Australia Limited (BDA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bod Australia Limited (BDA)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- Bod to commence importing medicinal cannabis oil 23 Feb 2018 10:05AM $0.440 $0.270 fallen by 38.64%
- Agreement with In2pharma & expansion of Health Product range 14 Feb 2018 12:17PM $0.440 $0.270 fallen by 38.64%
- Bod commences import of cannabis products 5 Feb 2018 9:39AM $0.575 $0.270 fallen by 53.04%
- Quarterly Report and Appendix 4C 24 Jan 2018 11:51AM $0.520 $0.270 fallen by 48.08%
- Agreement to develop Hemp Manuka Honey Product Line 18 Jan 2018 9:42AM $0.595 $0.270 fallen by 54.62%
- Update on Fast Track of Phase I Clinical Trials 11 Jan 2018 10:03AM $0.630 $0.270 fallen by 57.14%
- Agreement with iX Biopharma Ltd 4 Jan 2018 9:28AM $0.430 $0.270 fallen by 37.21%
- S708A Cleansing Notice 28 Dec 2017 1:43PM $0.380 $0.270 fallen by 28.95%
- Appendix 3B 28 Dec 2017 1:43PM $0.380 $0.270 fallen by 28.95%
- S708A Cleansing Notice 27 Dec 2017 10:43AM $0.385 $0.270 fallen by 29.87%
- Appendix 3B 27 Dec 2017 10:41AM $0.385 $0.270 fallen by 29.87%
- Becoming a substantial holder 22 Dec 2017 11:33AM $0.350 $0.270 fallen by 22.86%
- Bod Completes $3.2m Strategic Placement 18 Dec 2017 10:26AM $0.340 $0.270 fallen by 20.59%
- Trading Halt 14 Dec 2017 9:05AM $0.340 $0.270 fallen by 20.59%
- Strong growth and expansion of footprint into China 13 Dec 2017 11:26AM $0.335 $0.270 fallen by 19.40%
- Reinstatement to Official Quotation 8 Dec 2017 1:47PM $0.320 $0.270 fallen by 15.63%
- Bod Australia reinstated to Official Quotation 8 Dec 2017 1:46PM $0.320 $0.270 fallen by 15.63%
- Medicinal Cannabis Import Licence Granted 5 Dec 2017 10:22AM $0.320 $0.270 fallen by 15.63%
- Suspension from Official Quotation 5 Dec 2017 10:19AM $0.320 $0.270 fallen by 15.63%
- Trading Halt 1 Dec 2017 2:58PM $0.320 $0.270 fallen by 15.63%
- Investor Presentation 23 Nov 2017 10:13AM $0.245 $0.270 risen by 10.20%
- Change of Director's Interest Notice - Mickey Perret 21 Nov 2017 2:50PM $0.215 $0.270 risen by 25.58%
- Appendix 3B - Issue of Unlisted Options 17 Nov 2017 5:40PM $0.145 $0.270 risen by 86.21%
- Results of Annual General Meeting 15 Nov 2017 10:56AM $0.150 $0.270 risen by 80%
- Bod begins formulating cannabis-based cosmetics products 10 Nov 2017 8:20AM $0.155 $0.270 risen by 74.19%

201 - 225 of 284 results

Page 9 of 12

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.